Leichter Anna L, Sullivan Michael J, Eccles Michael R, Chatterjee Aniruddha
Department of Pathology, Dunedin School of Medicine, University of Otago, 56 Hanover Street, P.O. Box 913, Dunedin, 9016, New Zealand.
Royal Children's Hospital, Melbourne, VIC, Australia.
Mol Cancer. 2017 Jan 19;16(1):15. doi: 10.1186/s12943-017-0584-0.
The development of childhood solid tumours is tied to early developmental processes. These tumours may be complex and heterogeneous, and elucidating the aberrant mechanisms that alter the early embryonic environment and lead to disease is essential to our understanding of how these tumours function. MicroRNAs (miRNAs) are vital regulators of gene expression at all stages of development, and their crosstalk via developmental signalling pathways is essential for orchestrating regulatory control in processes such as proliferation, differentiation and apoptosis of cells. Oncogenesis, from aberrant miRNA expression, can occur through amplification and overexpression of oncogenic miRNAs (oncomiRs), genetic loss of tumour suppressor miRNAs, and global miRNA reduction from genetic and epigenetic alterations in the components regulating miRNA biogenesis. While few driver mutations have been identified in many of these types of tumours, abnormal miRNA expression has been found in a number of childhood solid tumours compared to normal tissue. An exploration of the network of key developmental pathways and interacting miRNAs may provide insight into the development of childhood solid malignancies and how key regulators are affected. Here we present a comprehensive introduction to the roles and implications of miRNAs in normal early development and childhood solid tumours, highlighting several tumours in depth, including embryonal brain tumours, neuroblastoma, osteosarcoma, Wilms tumour, and hepatoblastoma. In light of recent literature describing newer classifications and subtyping of tumours based on miRNA profiling, we discuss commonly identified miRNAs, clusters or families associated with several solid tumours and future directions for improving therapeutic approaches.
儿童实体瘤的发展与早期发育过程相关。这些肿瘤可能复杂且具有异质性,阐明改变早期胚胎环境并导致疾病的异常机制对于我们理解这些肿瘤的功能至关重要。微小RNA(miRNA)是发育各阶段基因表达的重要调节因子,它们通过发育信号通路的相互作用对于协调细胞增殖、分化和凋亡等过程中的调节控制至关重要。由异常miRNA表达引起的肿瘤发生可通过致癌miRNA(癌miRNA)的扩增和过表达、肿瘤抑制miRNA的基因缺失以及miRNA生物合成调节成分的遗传和表观遗传改变导致的整体miRNA减少而发生。虽然在许多这类肿瘤中仅发现了少数驱动突变,但与正常组织相比,在一些儿童实体瘤中已发现异常的miRNA表达。探索关键发育途径和相互作用的miRNA网络可能有助于深入了解儿童实体恶性肿瘤的发展以及关键调节因子是如何受到影响的。在此,我们全面介绍miRNA在正常早期发育和儿童实体瘤中的作用及影响,深入重点介绍几种肿瘤,包括胚胎性脑肿瘤、神经母细胞瘤、骨肉瘤、肾母细胞瘤和肝母细胞瘤。鉴于最近有文献描述基于miRNA谱的肿瘤新分类和亚型,我们讨论了与几种实体瘤相关的常见鉴定出的miRNA、簇或家族以及改善治疗方法的未来方向。